Evidence map›Paper›PMID 19608538›Full record

ArticleInvestigative ophthalmology & visual science2009

Retinol-binding site in interphotoreceptor retinoid-binding protein (IRBP): a novel hydrophobic cavity.

Federico Gonzalez-Fernandez, Thomas Bevilacqua, Kee-Il Lee, Reena Chandrashekar, Larson Hsu, Mary Alice Garlipp, Jennifer B Griswold, Rosalie K Crouch, Debashis Ghosh

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Interphotoreceptor retinoid binding protein; myths and mysteries.Journal of ophthalmic & vision research · 2012
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Federico Gonzalez-FernandezNeuroscience Graduate Program, State University of New York at Buffalo, Buffalo, New York, USA. fg23@buffalo.edu
Thomas Bevilacqua
Kee-Il Lee
Reena Chandrashekar
Larson Hsu
Mary Alice Garlipp
Jennifer B Griswold
Rosalie K Crouch
Debashis Ghosh
The California Eye Institute · USHauptman-Woodward Medical Research Institute · USMedical University of South Carolina · US

Funding

SYNTHETIC RETINAL PIGMENTS AND BINDING PROTEINSR01EY004939 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROUCH, ROSALIE K · 1985 to 2011
$4.2M
IRBP--STRUCTURE/FUNCTIONR01EY009412 · NEI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GHOSH, DEBASHIS, GONZALEZ-FERNANDEZ, FEDERICO · 1999 to 2011
$3.0M
IRBP--STRUCTURE AND FUNCTIONR29EY009412 · NEI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GONZALEZ-FERNANDEZ, FEDERICO · 1993 to 1997
–
NEI NIH HHS EY04939NEI NIH HHS EY09412NEI NIH HHS R01 EY004939NEI NIH HHS R01 EY009412
6 · The paper itself

Abstract

purposeInterphotoreceptor retinoid-binding protein (IRBP) appears to target and protect retinoids during the visual cycle. X-ray crystallographic studies had noted a betabetaalpha-spiral fold shared with crotonases and C-terminal protein transferases. The shallow cleft formed by the fold was assumed to represent the retinol-binding site. However, a second hydrophobic site consisting of a highly restricted cavity was more recently appreciated during in silico ligand-docking studies. In this study, the ligand-binding environment within the second module of Xenopus IRBP (X2IRBP) is defined.

methodsPristine recombinant polypeptide corresponding to X2IRBP was expressed in a soluble form and purified to homogeneity without its fusion tag. Phenylalanine was substituted for tryptophan at each of the putative retinol-binding domains (W450F, hydrophobic cavity; W587F, shallow cleft). Binding of 11-cis and all-trans retinol were observed in titrations monitoring retinol fluorescence enhancement, quenching of tryptophan fluorescence, and energy transfer. The effect of oleic acid on retinol binding was also examined.

resultsA ligand-binding stoichiometry of approximately 1:1 was observed for 11-cis and all-trans with K(d) in the tens of nanomolar range. The substitution mutants showed little effect on retinol binding in titrations after fluorescence enhancement. However, the W450F and not the W587F mutant showed a markedly reduced capacity for fluorescence quenching for both 11-cis and all-trans retinol. Oleic acid inhibited the binding of 11-cis and all-trans retinol in an apparent noncompetitive manner.

conclusionsThe binding site for 11-cis and all-trans retinol is a novel hydrophobic cavity that is highly restrictive and probably distinct from the long chain fatty acid-binding site.

Indexed as

AnimalsBinding SitesEye ProteinsLigandsMutagenesis, Site-DirectedOleic AcidProtein ConformationRecombinant ProteinsRetinol-Binding ProteinsRetinol-Binding Proteins, InterstitialSpectrometry, FluorescenceVitamin AXenopus laevisEye ProteinsLigandsOleic AcidRecombinant ProteinsRetinol-Binding ProteinsRetinol-Binding Proteins, InterstitialVitamin A

Identifiers

PMID19608538
PMCPMC5568800
OpenAlexW2032801984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.